<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with rare <z:hpo ids='HP_0001548'>overgrowth</z:hpo> disorders, such as Beck-<z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Wiedemann syndrome</z:e> and <z:e sem="disease" ids="C0796154" disease_type="Disease or Syndrome" abbrv="SDYS">Simpson-Golabi-Behmel syndrome</z:e>, are predisposed to <z:e sem="disease" ids="C0027654" disease_type="Neoplastic Process" abbrv="">embryonal tumours</z:e>, including <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour of the kidney</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, these disorders offer a link between hyperplastic growth and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Genetic lesions at chromosome 11p15 have been associated with Beck-<z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Wiedemann syndrome</z:e> and <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour</z:e> for several years and the presence of the gene encoding insulin-like growth factor-II (IGF-II) in this region has given rise to much speculation over the involvement of this factor in these growth defects </plain></SENT>
<SENT sid="3" pm="."><plain>This speculation was heightened by genetic evidence for the involvement of <z:mp ids='MP_0003121'>genomic imprinting</z:mp> in Beck-<z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Wiedemann syndrome</z:e> and <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour</z:e>, combined with the discovery that the IGF-II gene is imprinted </plain></SENT>
<SENT sid="4" pm="."><plain>Although there is a wealth of evidence linking the IGF signalling pathway with <z:hpo ids='HP_0001548'>overgrowth</z:hpo> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, recent progress in the study of 11p15 and developments in our understanding of the mechanism of <z:mp ids='MP_0003121'>genomic imprinting</z:mp> indicate that additional imprinted genes located in this region also contribute to these growth disorders </plain></SENT>
</text></document>